Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements

  • Yong Eun Park
  • , Yoo Jin Lee
  • , Ji Young Chang
  • , Hyun Joo Song
  • , Duk Hwan Kim
  • , Young Joo Yang
  • , Byung Chang Kim
  • , Jae Gon Lee
  • , Hee Chan Yang
  • , Miyoung Choi
  • , Seong Eun Kim
  • , Seung Jae Myung

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Many unexpected problems have resulted from the unprecedented coronavirus disease 2019 (COVID-19) pandemic. The optimal management of patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic has also been a challenge. Therefore, the Korean Association for the Study of Intestinal Diseases (KASID) developed a consensus statement of experts regarding the management of IBD during the COVID-19 pandemic. This consensus statement made recommendations regarding the risk and treatment of COVID-19 in IBD patients.

Original languageEnglish
Pages (from-to)431-444
Number of pages14
JournalIntestinal Research
Volume20
Issue number4
DOIs
StatePublished - Oct 2022

Bibliographical note

Publisher Copyright:
© Copyright 2022. Korean Association for the Study of Intestinal Diseases. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords

  • Covid-19
  • Inflammatory bowel disease
  • Management
  • Sars-cov-2

Fingerprint

Dive into the research topics of 'Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements'. Together they form a unique fingerprint.

Cite this